CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sirtris Pharmaceuticals, Inc. (NASDAQ: SIRT), a biopharmaceutical company focused on discovering and developing small molecule drugs to treat diseases of aging such as Type 2 Diabetes, announced today that it will be presenting at the ThinkEquity G5 Growth Conference on September 18, 2007 at 9:30 a.m. PST, and the Bank of America 37th Annual Investment Conference at 4:30 p.m. PST, both in San Francisco.
